Evidence map›Paper›PMID 38655006›Full record

ArticleInternational journal of general medicine2024

Analysis of Factors Influencing Prognosis and Assessment of 60 Cases of Decompensated Cirrhotic Patients with Portal Hypertension.

Xue Fang Li, Shi Rong Liu, Jin Jin Li, Ning Liu, Hui Min Li, An Ning Ge, Liang Liang Wang, Xie Min Dong, Hui Wang, Ju Liu and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Xue Fang LiDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.ORCID 0009-0003-6783-7403
Shi Rong LiuInfectious Diseases department, People's Hospital of Qu fu City, Qufu City, Shandong Province, People's Republic of China.
Jin Jin LiDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.
Ning LiuInfectious Diseases department, People's Hospital of Qu fu City, Qufu City, Shandong Province, People's Republic of China.ORCID 0009-0005-5535-3764
Hui Min LiInfection Department, Jiaozhou Branch of Shanghai East Hospital Tongji University, Qingdao City, Shandong Province, People's Republic of China.
An Ning GeDepartment of Infectious Diseases, People's Hospital of Rizhao City, Rizhao City, Shandong Province, People's Republic of China.
Liang Liang WangMedical Intervention Department, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.
Xie Min DongDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.
Hui WangDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.
Ju LiuDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.
Lin ZhangDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.
Hao Dong ZhangDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.
Wei GouDepartment of Metabolic Liver Disease, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province, People's Republic of China.ORCID 0009-0004-4405-3646
Qingdao Eighth People's Hospital · CNQuzhou City People's Hospital · CNPeople’s Hospital of Rizhao · CNShanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the risk factors for the development of portal hypertension in patients with decompensated cirrhosis and analyze their prognosis. Methods: Patients with decompensated cirrhosis who were admitted to our hospital and Qu fu People's Hospital from June 2022 to June 2023 were included in this study. Among them, there were 45 male and 15 female patients, with a median age of 56 (range: 35-77) years. A comparative analysis was performed between Group A (hepatic venous pressure gradient, HVPG <16 mmHg) and Group B (HVPG ≥16 mmHg) patients, along with various clinical outcomes. Multivariate analysis was conducted to explore the risk factors influencing the occurrence of portal hypertension and adverse prognosis in patients with cirrhosis. Results: In Group A patients with portal hypertension, we observed lower levels of aspartate aminotransferase, laminin, serum hyaluronic acid, type III procollagen N-terminal peptide, total bile acids, and cholylglycine acid compared to Group B. On the other hand, levels of alanine aminotransferase, white blood cells, and serum albumin were higher in Group A than in Group B. These differences between the groups were statistically significant (P < 0.05). Multivariate analysis of the aforementioned risk factors indicated that low white blood cell count, high cholylglycine acid levels, and high serum hyaluronic acid levels were identified as independent risk factors for the occurrence of difficult-to-control complications in decompensated portal hypertension among patients with liver cirrhosis (P < 0.05). Conclusion: Liver cirrhosis patients with portal hypertension and multiple risk factors like low white blood cell count and high liver transaminase levels should be cautious regarding the progression of portal hypertension when combined with splenomegaly, liver fibrosis, and bile stasis, as it often indicates a poor prognosis.

Indexed as

glycine cholateportal hypertensionserum hyaluronic acidwhite blood cells

Identifiers

PMID38655006
PMCPMC11036329
OpenAlexW4394935217

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.